Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Stephen Falk"'
Autor:
Gareth Griffiths, Simon Gollins, Lisette Sheena Nixon, John Staffurth, R Roy, Stephen Falk, J I Geh, Jonathan Rees, Jane M Blazeby, Ruby Ray, N Bashir, Chris Nicholas Hurt, S. Mukherjee, Tom Crosby, David Cunningham, Tim Maughan, John Bridgewater
Publikováno v:
Rees, J R E, Hurt, C N, Gollins, S, Mukherjee, S, Maughan, T, Falk, S J, Staffurth, J, Ray, R, Bashir, N, Geh, J I, Cunningham, D, Roy, R, Bridgewater, J, Griffiths, G, Nixon, L S, Blazeby, J M & Crosby, T 2015, ' Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer ', British Journal of Cancer, vol. 113, no. 4, pp. 603-610 . https://doi.org/10.1038/bjc.2015.258
British Journal of Cancer
British Journal of Cancer
BACKGROUND:Limited data describe patient-reported outcomes (PROs) of localised oesophageal cancer treated with definitive chemoradiotherapy(CRT). The phase 2/3 SCOPE-1 trial assessed the effectiveness of CRT±cetuximab. The trial for the first time p
Autor:
Jenny L Donovan, William Hollingworth, Caroline Wilson, Christopher Streets, S. M. Griffin, Tom Crosby, Dan Titcomb, Jane M Blazeby, R. Krysztopik, Sean Strong, CP Barham, Sara T Brookes, Stephen Falk, James L. Nicklin, A D Hollowood
Publikováno v:
British Journal of Cancer
Background: The optimal treatment for localised oesophageal squamous cell carcinoma (SCC) is uncertain. We assessed the feasibility of an RCT comparing neoadjuvant treatment and surgery with definitive chemoradiotherapy. Methods: A feasibility RCT in
Autor:
Jaffer A. Ajani, Juan W. Valle, David Ferry, D Albert, E. Van Cutsem, J. Chick, H Glen, Stephen Falk, Alan Anthoney, Daniel W. Drolet, Martin Eatock
Publikováno v:
British Journal of Cancer
A two-stage Simon design was used to evaluate the response rate of OSI-7904L, a liposome encapsulated thymidylate synthase inhibitor, in advanced gastric and/or gastroesophageal adenocarcinoma (A-G/GEJA), administered intravenously at 12 mg m(-2) ove